EQUITY (Details Narrative) - USD ($)				3 Months Ended
EQUITY (Details Narrative) - USD ($)	Mar. 02, 2021	Jul. 31, 2019	Apr. 30, 2018	Jun. 30, 2021	Jun. 30, 2020	Mar. 31, 2021	Dec. 31, 2020
Class of Stock [Line Items]
Common stock par value				$ 0.01		$ 0.01
Preferred Stock, Par or Stated Value Per Share				$ 0.01		$ 0.01
Preferred Stock, Shares Authorized				19,800,000		19,800,000
Common Stock, Shares Authorized				40,000,000		40,000,000
Common Stock, Shares, Issued				13,268,871		9,983,082
Common Stock, Shares, outstanding				13,268,871		9,983,082
Share issued during period, value				$ 553,002	$ 375,000
Common stock subscription, shares						2,978,611
Common stock subscription, value						$ 1,191,442
Amortized stock option expense				10,557	1,048
outstanding stock options intrinsic value				$ 63,274	45,011
Remaining contractual term				1 year 4 months 20 days
Intrinsic value of outstanding warrants				$ 0
2018 Stock Option And Incentive Plan [Member]
Class of Stock [Line Items]
Reserving stock option issuance			2,697,085
2019 Stock Option And Incentive Plan [Member]
Class of Stock [Line Items]
Number of stock option grant		2,000,000
Expiration date		May 21, 2029
2020 Stock Option and Incentive Plan [Member]
Class of Stock [Line Items]
Number of stock option grant							2,000,000
Common Stock [Member]
Class of Stock [Line Items]
Sale of stock price per share				$ 0.40
Share issued during period, value
Number of warrant issued				4,200,000
Number of warrant exercise price				$ 1.20
Warrant terms				3 years
Common Stock [Member] \| Amendment of Preferred Stock [Member]
Class of Stock [Line Items]
Share issued during period stock exchanged, shares				307,178
Share issued during period, value				$ 122,876
Non-Qualified Stock Options [Member]
Class of Stock [Line Items]
Stock options number of shares				250,000	120,000
Vesting terms				2 years	2 years
Series A Preferred Stock [Member]
Class of Stock [Line Items]
Sale of stock, shares				4,200,000
Sale of stock price per share				$ 0.80
Excess outstanding shares				550,000
Preferred Stock, Par or Stated Value Per Share				$ 0.01		$ 0.01
Preferred Stock, Shares Authorized				4,200,000		4,200,000
Series A-1 Preferred Stock [Member]
Class of Stock [Line Items]
Common stock par value				$ 0.40
Share purchased value				$ 6,000
Share issued during period stock exchanged, shares				1,437,500
Series A-1 and Series A-2 Preferred Stock [Member] \| IPO [Member]
Class of Stock [Line Items]
Purchased share discount percentage				10.00%
Series A-2 Preferred Stock [Member]
Class of Stock [Line Items]
Share issued during period stock exchanged, shares				2,212,500
Series B Preferred Stock [Member]
Class of Stock [Line Items]
Sale of stock, shares				4,320,156
Sale of stock price per share				$ 0.80	$ 0.80
Excess outstanding shares				286,250
Preferred Stock, Par or Stated Value Per Share				$ 0.01		$ 0.01
Preferred Stock, Shares Authorized				6,000,000		6,000,000
Dividends percentage				10.00%
Proceeds from issuance of sale of stock				$ 3,456,124
Series B Preferred Stock [Member] \| Common Stock [Member]
Class of Stock [Line Items]
Common stock par value	$ 0.40
Series B-1 Preferred Stock [Member]
Class of Stock [Line Items]
Sale of stock, shares				691,250
Share purchased value	$ 6,000
Share issued during period stock exchanged, shares				1,857,656
Series B-1 And Series B-2 [Member] \| IPO [Member]
Class of Stock [Line Items]
Purchased share discount percentage	10.00%
Series B-2 Preferred Stock [Member]
Class of Stock [Line Items]
Share issued during period stock exchanged, shares				2,176,250

Kyto Technology & Life Science, Inc. 10-Q/A